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Changes to the immune system after stroke are complex and can result in both pro- 
inflammatory and immunosuppressive consequences. Following ischemic stroke, brain 
resident microglia are activated and circulating monocytes are recruited to the injury 
site. In contrast, there is a systemic deactivation of monocytes/macrophages that may 
contribute to immunosuppression and the high incidence of bacterial infection experi-
enced by stroke patients. The manipulation of macrophage subsets may be a useful 
therapeutic strategy to reduce infection and improve outcome in patients after stroke. 
Recent research has enhanced our understanding of the heterogeneity of macrophages 
even within the same tissue. The spleen is the largest natural reservoir of immune cells, 
many of which are mobilized to the site of injury after ischemic stroke and is notable 
for the diversity of its functionally distinct macrophage subpopulations associated with 
specific micro-anatomical locations. Here, we describe the effects of experimental stroke 
in mice on these distinct splenic macrophage subpopulations. Red pulp (RP) and mar-
ginal zone macrophages (MZM) specifically showed increases in density and alterations 
in micro-anatomical location. These changes were not due to increased recruitment 
from the bone marrow but may be associated with increases in local proliferation. 
Genes associated with phagocytosis and proteolytic processing were upregulated in 
the spleen after stroke with increased expression of the lysosome-associated protein 
lysosomal-associated membrane proteins specifically increased in RP and MZM sub-
sets. In contrast, MHC class II expression was reduced specifically in these populations. 
Furthermore, genes associated with macrophage ability to communicate with other 
immune cells, such as co-stimulatory molecules and inflammatory cytokine production, 
were also downregulated in the spleen after stroke. These findings suggest that selec-
tive splenic macrophage functions could be impaired after stroke and the contribution 
of macrophages to stroke-associated pathology and infectious complications should 
be considered at a subset-specific level. Therefore, optimal therapeutic manipulation 
of macrophages to improve stroke outcome is likely to require selective targeting of 
functionally and spatially distinct subpopulations.
Keywords: stroke, immunosuppression, spleen, macrophages, infection
Abbreviations: DC, dendritic cells; FDC, follicular dendritic cells; MARCO, macrophage receptor with a collagenous structure; 
MMM, marginal zone metallophillic macrophage; MZ, marginal zone; MZDC, marginal zone dendritic cell; MZM, marginal 
zone macrophage; PALS, peri-arteriolar lymphoid sheath; PRR, pattern recognition receptor; RP, red pulp; RPM, red pulp 
macrophage; SAI, stroke-associated infection; TBM, tingible body macrophage; TLR, toll-like receptor; WP, white pulp.
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inTrODUcTiOn
Stroke induces rapid and complex effects on the systemic immune 
system. Immune cells including monocytes/macrophages infil-
trate the brain after stroke and original studies suggested that they 
exacerbate inflammation and injury (1–3). However, prevention 
of monocyte/macrophages from entering the brain in the acute 
phase after ischemic stroke has been shown to worsen outcome, 
and we now know that certain subpopulations can be beneficial 
for injury repair and recovery (4–7). Conversely, there is a con-
current suppression of systemic immune responses including loss 
of B and T lymphocytes (8, 9), atrophy of immune organs (10) and 
functional deactivation of monocytes (11, 12). This contributes to 
a susceptibility to infection, which is the most common complica-
tion of stroke. Stroke-associated infection (SAI) affects up to one 
third of patients and is independently associated with increased 
mortality and morbidity (13, 14). Reducing infection in stroke 
patients may provide a useful strategy to improve clinical outcome; 
however, successful therapeutics must restore peripheral immune 
defenses without exacerbating harmful brain inflammation and 
injury. The spleen has been identified as an important reservoir 
of monocytes which are mobilized in response to inflammation 
(15). Furthermore, the spleen undergoes extensive atrophy due to 
apoptosis of resident immune cell populations after experimental 
and clinical stroke which is potentially compounded by neural 
stimulation of the smooth muscle surrounding the capsule induc-
ing splenic contraction (8, 10, 14, 16). For this reason, splenic 
macrophages may have multiple contributions to the neuroim-
mune mechanisms influencing stroke and have been identified 
as a potential therapeutic target for both preventing excessive 
harmful inflammation in the brain and reducing immunosup-
pression after stroke (5, 17).
The spleen is comprised of two functionally distinct compart-
ments. The red pulp (RP) functions as a blood filter to remove 
dead erythrocytes, acts as a storage site for erythrocytes, platelets, 
and iron, and in rodents is a site of hematopoiesis. The white 
pulp (WP) is a highly organized immune compartment crucial 
in the defense against systemic infection and is surrounded by a 
marginal zone (MZ), which acts as an interface between the circu-
lation and cells of the immune system (18). Specific populations of 
macrophages exist in each of these functionally distinct compart-
ments. Splenic macrophages are a heterogeneous population with 
respect to origin, micro-anatomical location, and surface receptor 
expression but contribute in complementary ways to maintain 
homeostasis, reduce blood-borne infection, and induce effective 
immune responses.
Red pulp macrophages (RPM) in the spleen can be divided into 
F4/80hi CD11b−/lo and F4/80+ CD11b+ populations with distinct 
developmental lineages and functions (19). F4/80hi CD11b−/lo  
comprise the majority of RPM and are a CSF-1-dependent, self- 
renewing, tissue resident macrophage population derived from 
the fetal liver (19, 20). In contrast, F4/80+ CD11b+ RPM are 
monocyte-derived macrophages and have a smaller contribution 
to the RPM pool. These cells are replenished from bone marrow 
hematopoietic precursors at low levels in steady state but can 
aid replenishment of tissue-resident RPM in conditions that 
induce macrophage depletion and as such express the chemokine 
receptor CCR2 (19, 21, 22). Both populations are responsible for 
the clearance of senescent red blood cells and degrade hemo-
globin to transport the free iron back into the circulation (23). 
These functions are crucial for systemic iron metabolism and the 
removal of potentially harmful self-antigen from dying cells in 
the circulation but are additionally important for antibacterial 
defenses through the sequestration of free iron to limit bacterial 
growth. RPM can also differentially influence the development of 
adaptive immune responses. F4/80+ CD11b+ RPM are reported to 
have potent antigen-presenting capabilities, produce pro-inflam-
matory cytokines, and can induce T  cell proliferation in  vitro, 
whereas F4/80hi CD11b−/lo RPM produced anti-inflammatory 
cytokines and induced the differentiation of regulatory T  cells 
thought to be important for regulation of autoimmune responses 
to self-antigen filtered in the RP (19, 21).
Arterial blood entering the spleen interacts with two popula-
tions of non-motile macrophages in the MZ allowing surveillance 
of pathogens in the circulation. Localization of marginal zone 
macrophages (MZM) and marginal metallophillic macrophages 
(MMM) at the interface between the circulation and organized 
lymphoid tissue in the WP allow them to act as a bridge between 
the innate and adaptive immune responses. The origin of mac-
rophages in the MZ is currently uncertain but mice deficient in 
the nuclear receptor LXRα have a specific deficiency in MMM 
and MZM which is restored upon transfer of WT monocytes 
suggesting they can be replenished from bone marrow-derived 
progenitors (24). MZM line the marginal sinus on the external 
side and are defined by expression of the macrophage scavenger 
receptor MAcrophage Receptor with a COllagenous structure, 
MARCO (25). MMM are localized at the inner side of the marginal 
sinus forming a ring around the periarteriolar lymphocyte sheath 
(PALS) and follicular areas of the WP and can be distinguished 
using the monoclonal antibody MOMA-1 (CD169) (26). MZ 
macrophage populations express a variety of pattern recognition 
receptors (PRR) allowing efficient recognition and clearance 
of pathogens crucial in the defense against systemic infection. 
The clearance of viral, parasitic, and bacterial pathogens by MZ 
macrophages has been shown to be essential for early contain-
ment of infection (27–29). MMM uniquely express nonspecific 
esterase, which is important in the neutralization of LPS (30). 
Additionally, both MZ macrophage populations have roles in the 
clearance of apoptotic cells and suppressing immune responses to 
self-antigen present in cellular debris (31). MARCO+ MZM in the 
spleen can regulate B cell transport of antigen to the follicle (32). 
MOMA-1+ MMM can transport bacteria to splenic WP to allow 
subsequent waves of innate immune responses and an analogous 
MOMA-1+ macrophages in the subcapsular sinus of the lymph 
node have been shown to directly transport antigen to the fol-
licular dendritic cells (FDC) (33, 34), processes that are crucial 
in the germinal center (GC) reaction to allow the development of 
high affinity antibody responses.
Within the WP, tingible body macrophages (TBM) are found 
in the B  cell follicles and are responsible for the clearance of 
apoptotic lymphocytes that arise as the result of the GC reaction 
(35). TBM clearance of apoptotic cells is dependent on MFGE-8 
produced by FDC and defects in these pathways are also linked to 
increased autoimmune responses (36). Dendritic cells (DC) are 
3McCulloch et al. Stroke-Induced Effects on Splenic Macrophages
Frontiers in Immunology | www.frontiersin.org May 2018 | Volume 9 | Article 1108
also present in the WP and MZ and share some similar functions 
to macrophages but are specialized for antigen collection, pro-
cessing, and transport to secondary lymphoid organs for presen-
tation to T cells (37, 38). DC in the MZ (MZ DC) have additional 
abilities and can prime B cells to initiate antibody responses and 
regulate peripheral tolerance to self-antigen (39, 40).
In the present study, we determined the effects of experimental 
stroke on these individual populations and analyzed their loca-
tion and density within the splenic micro-environment. We have 
shown that splenic macrophage subpopulations were differen-
tially affected by experimental stroke and that increased local 
densities of both subsets of RPM, and MZM did not result from 
increased recruitment of precursors from the bone marrow but 
may instead be associated with increases in local proliferation. 
Furthermore, the same subsets show evidence supporting func-
tional changes including increased phagocytosis and reduced 
expression of MHC Class II after experimental stroke. Genome-
wide analysis of splenocytes after stroke indicated that genes 
associated with macrophage ability to detect infection and recruit 
and activate other immune cells were also reduced after stroke 
including those encoding expression of PRR, co-stimulatory 
molecules, and pro-inflammatory cytokines. These data suggest 
further investigations of the functional consequences of stroke 
at a subpopulation-specific level are warranted and will provide 
the optimal basis to identify therapeutic targets to augment 
macrophage function and reduce SAI without exacerbating their 
potentially brain-damaging actions or compromising pro-repair 
mechanisms within the injured brain.
MaTerials anD MeThODs
animals
Male 8–10-week-old C57BL/6J mice were purchased (Charles 
River Laboratories, UK) and used in all experiments unless 
otherwise stated. CCR2RFP/+ transgenic mice were used where 
stated and have been previously described (41). Breeding pairs 
of CCR2RFP/+ reporter mice on a C57BL/6J background, were 
purchased from Jackson Laboratories (ME, USA) and a colony 
was established in house. Mice were maintained under SPF condi-
tions and a standard 12-h light/dark cycle with unrestricted access 
to food and water. Mice were housed in individually ventilated 
cages in groups of up to five mice and those bought from external 
suppliers were acclimatized for a minimum of 1  week prior to 
procedures. All animal experiments were carried out under the 
authority of a UK Home Office Project License in accordance 
with the “Animals (Scientific procedures) Act 1986” and Directive 
2010/63/EU and were approved by both The Roslin Institute’s and 
the University of Edinburgh’s Animal Welfare and Ethics Review 
Board. Experimental design, analysis, and reporting followed the 
ARRIVE guidelines (https://www.nc3rs.org.uk/arrive-guidelines).
experimental stroke Model and Tissue 
harvesting
Middle cerebral artery occlusion (MCAO) was performed under 
isoflourane anesthesia (with O2 and N2O) by insertion of a 6-0 
nylon monofilament with a 2 mm coated tip (210 µm diameter; 
Doccol, USA) through the external carotid artery and advanced 
through the internal carotid artery to occlude the MCA. The 
filament was withdrawn after 40 min to allow reperfusion, the 
neck wound sutured, and the animals recovered. Topical local 
anesthetic (lidocaine/prilocaine) was applied to the wound. For 
sham surgery, the filament was advanced to the MCA and imme-
diately retracted. Sham-operated animals remained anesthetized 
for 40  min and recovered as above. Core body temperature 
was maintained at 37 ±  0.5°C throughout the procedure with 
a feedback controlled heating blanket (Harvard Aparatus). 
Animals were recovered for 1–7 days then anesthetized and anti-
coagulated (3.8% w/v tri-sodium citrate) cardiac blood samples 
were taken followed by transcardiac perfusion with saline. Brains 
were harvested and frozen in isopentane at −35 to −45°C over 
dry ice. Spleens used for flow cytometric analysis were harvested 
into ice cold PBS. For immunohistochemical analysis, spleens 
from C57Bl/6 mice were snap frozen on dry ice and all tissues 
were stored at −80°C until sections cut. Spleens from Ccr2RFP/+ 
reporter mice were perfused with saline and immersion fixed 
overnight in 4% paraformaldehyde. Samples were rinsed in dH2O 
and immersed in 20% sucrose at 4°C for 24  h. Excess sucrose 
was removed from sample by blotting on absorbent tissue and 
samples were frozen in isopentane at −35 to −45°C over dry ice 
and stored at −80°C until sections cut.
immunohistochemistry and analysis  
of spleens
Serial frozen sections of spleen (6 µm in thickness) were cut on 
a cryostat, fixed in ice-cold acetone for 10 min, washed in 0.05% 
BSA in PBS, and blocked using species-specific normal serum 
(Jackson Immunoresearch Laboratories Inc., PA, USA) according 
to secondary antibody used. Primary antibodies were incubated 
for 1  h at room temperature. Splenic macrophage populations 
were visualized by staining for F4/80 (1  µg/ml; clone BM8, 
Biolegend, CA, USA), CD11b (5 µg/ml; clone M1/70, eBiosci-
ence, ThermoFisher Scientific, Paisley, UK), MOMA-1 to detect 
CD169 (2.5 µg/ml; Siglec 1; clone 3D6.112, Biolegend), MARCO 
(10 µg/ml; clone ED31, AbD Serotec, Kidlington, UK), MOMA-2 
(1  µg/ml; clone MOMA2; Abcam, Cambridge, UK) or CD68 
(5  µg/ml; clone FA-11; Biolegend). Monocytes/Granulocytes 
were visualized by staining for Ly6C (1  µg/ml; clone HK1.4; 
Biolegend). Neutrophils were visualized using Ly6G (1  µg/ml; 
clone 1A8; Biolegend) and SJC4 (1/10,000; polyclonal; Anthony 
lab, Oxford). DC populations were visualized by staining for 
CD11c (1 µg/ml; clone N4/18, Biolegend) and DEC205 (5 µg/ml; 
clone NLDC-145, Biolegend). Proliferating cells were visual-
ized by staining with KI-67 (1  µg/ml; clone 16A8, Biolegend). 
Macrophage-associated proteins were visualized by staining for 
MHC II to detect IA/IE (0.5 µg/ml; clone M5/114/15.2, Biolegend) 
and lysosomal-associated membrane proteins (LAMP2) to detect 
CD107b (0.5 µg/ml; clone M3/84, Biolegend). Following the addi-
tion of primary antibody, sections were washed in PBS-BSA. For 
unconjugated primary antibodies, 2.5  µg/ml of species-specific 
secondary antibody coupled to Alexa Fluor® 488, Alexa Fluor® 
594 dyes or Alexa Fluor® 647 fluorochromes (Life Technologies 
Ltd, Paisley, UK) were incubated for 1  h at room temperature. 
Table 1 | RT2 qPCR primer assays (no sequence available).
Protein gene 
symbol
gene iD reference position catalog 
number
TNFα Tnf 21926 194 (NM_013693) PPM0113G
CD40 Cd40 21939 885 (NM_011611) PPM03426C
Cathepsin L Ctsl 13039 898 (NM_009984) PPM03691C
GAPDH Gapdh 14433 478 (NM_008084) PPM02946E
Lamp2 Lamp2 16784 1152 (NM_001017959) PPM24540E
TLR 1 Tlr1 21897 2334 (NM_030682) PPM04211B
4
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Sections were washed in PBS-BSA and mounted in fluorescent 
mounting medium (Dako, Cambridgeshire, UK) and images cap-
tured using a Zeiss LSM5 confocal microscope (Zeiss, Welwyn 
Garden City, UK).
Digital images were analyzed using ImageJ software. All 
spleens from each experimental group were analyzed. From each 
spleen, two sections, 100  µm apart, were studied and on each 
section data from four individual areas of WP were collected. 
Fluorescent intensity thresholds were applied, and the number 
of pixels of each color (black, red, green, yellow) was automati-
cally counted as previously described (42) and used to determine 
the area of immunolabelling for each antibody. To analyze MZ 
specific immunolabelling, a border was firstly drawn to separate 
the MZ from the follicle using MZ macrophage immunolabelling 
as a guide. The area of WP and MZ zone specific immunolabelling 
was determined separately.
Flow cytometry
Mouse spleens were mechanically dissociated and red blood cells 
were lysed. Resulting single cell suspensions were used for flow 
cytometric analysis of macrophage populations and CCR2-RFP 
expression. Briefly, cell surface staining to allow the detection of 
macrophage subpopulations was carried out using antibodies 
against F4/80-PercP-Cy5 (clone BM8; Biolegend, 1  µg/ml), 
CD11b-APC-Cy7 (clone M1/70; Biolegend, 1  µg/ml), MOMA-
1-PE (CD169; clone3D6.112; Biolegend, 2 µg/ml), and MARCO 
(clone ED31; Bio-rad, 5 µg/ml). Cells were incubated in anti-mouse 
CD16/32 (clone 93; Affymetrix eBioscience, 0.4 µg/ml) for 10 min 
to block Fc receptors then fluorescently conjugated primary anti-
body cocktails for 30 min at room temperature. Cells were washed 
in PBS and flow cytometry was performed on a Becton Dickinson 
LSR Fortessa and analyzed by Summit software (Dako). Live cells 
were gated based on FSC and SSC and 20,000 cells in this gate 
collected for each sample.
Microarray
Microarray analysis combined previously published analysis of 
sham and 5 days post-MCAO datasets (NCBI Geodataset data-
base accession number GSE70841) with further unpublished 
datasets from mice recovered 1 and 2 days after MCAO to provide 
a new analysis. RNA was isolated from 1/4 spleens from sham-
operated C57Bl/6J mice or those recovered from MCAO for 1, 2, 
or 5 days using the Qiagen RNeasy mini kit (Qiagen, Manchester, 
UK). RNA integrity and quality were verified using Agilent 
BioAnalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA). 
RNA was reverse-transcribed to cDNA, amplified, and labelled 
using the Affymetrix terminal labeling kit (Affymetrix, Santa 
Clara, CA, USA), according to the manufacturer’s instructions. 
Samples were hybridized to MoGene 1.0 ST chips (Affymetrix) 
using GeneTitan Hybridization, Wash and Stain kit for WT array 
plates (Affymetrix), stained, and scanned by Edinburgh Genomics 
(Edinburgh, UK). Raw data (.cel) files were normalized directly 
during import for analysis in Partek Genomics Suite (Partek Inc, 
MO, USA). Probesets were annotated using MoGene-1_0-st-v1 
Probeset Annotations, Release 35. To determine which transcripts 
were changed due to experimental stroke, normalized datasets 
were compared in Transcriptome Analysis Console (Affymetrix) 
by ANOVA. Expression of specific transcripts of interest was 
determined using normalized raw data in excel. Microarray data 
are deposited in the NCBI GeoDatasets database with the acces-
sion number GSE108875.
cytometric bead array
Cytometric bead array was used to measure splenic cytokine 
concentrations. 1/4 spleens were homogenized to a 20% weight/
volume concentration in buffer containing 50  mM Tris-HCl 
pH6.7; 150 mM NaCl; 5 mM CaCl2; 1% TritonX; and 1× protease 
inhibitor cocktail set 1 (Merck, Calbiochem, Hertfordshire, UK). 
BD™ CBA flex Set containing mouse cytometric bead arrays for 
IL-1α; IL-4; IL-6; IL-10; G-CSF; CCL-2; CXCL-1; and TNFα was 
used according to manufacturer’s instructions (BD Biosciences, 
Oxford, UK). Briefly, spleen homogenates were diluted 1:1 in 
assay diluent, standards were prepared according to manufac-
turer’s instructions and both were added to plate with a cocktail 
of cytokine-specific beads and incubated for 1  h on a shaker. 
PE-conjugated cytokine-specific secondary antibody cocktail was 
prepared according to manufacturer’s instructions, added to plate, 
and incubated for a further 1  h. Beads were washed and then 
resuspended in PBS. Beads were acquired on a BD FACS Array 
cytometer and data were analyzed using FCAP Array™ Software.
splenic MZ antigen capture
To assess the capture and transport of antigen by MZ cells in vivo, 
naïve mice or mice recovered 48  h after sham or MCAO, were 
administered 20  µg of 3,000  kDa Dextran conjugated to FITC 
(Sigma, Dorset, UK) by intravenous injection. Spleens were 
removed either 1 or 24 h after injection, snap frozen on dry ice and 
5 µm sections cut on a cryostat. The presence of MZ cell-associated 
or FDC-associated fluorescent antigen was identified by immuno-
histochemistry and analyzed in ImageJ as described above.
Quantitative real-Time Polymerase  
chain reaction (qrT-Pcr)
500  ng of total RNA prepared for microarray (as above) was 
reverse–transcribed using superscript III Reverse transcriptase 
(Life technologies) according to manufacturer’s instructions. 
RT-qPCR was carried out on a Stratagene Mx3005P instrument 
(Agilent Technologies) using either RT2 SYBR® Green qPCR 
mastermix (Qiagen) and RT2 qPCR primer assays for Gapdh, 
Tlr1, Cd40, Tnf, Lamp2, and Ctsl or Platinum SYBR® Green qPCR 
SuperMix-UDG (Invitrogen, USA) and KiCqStart™ SYBR® 
Green primers (Sigma) for Cd163 and Lcn2 as detailed in Tables 1 
and 2, respectively, according to manufacturer’s instructions. 
Table 2 | KiCqStart SYBR Green primers.
Protein gene symbol gene iD sequence  
5′- 3′ F
sequence  
5′- 3′ r
Lipocalin2 Lcn2 16819 ATATGCACAG 
GTATCCTCAG
GAAACGTTCCT 
TCAGTTCAG
CD163 Cd163 93671 AGTCTGCTCAC 
GATACATAG
TCCTTCTGGAAT 
AGATTGGG
5
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qPCR cycles were performed as follows: hot-start denaturation 
cycle 95°C for 10 min, 40 cycles of amplification of 95°C for 15 s 
and 60°C for 1 min ΔCt (Ct of housekeeping gene, Gapdh, minus 
Ct of gene of interest) was calculated for each sample. Data are 
expressed as the normalized expression ratio (2(−ΔΔCt)) in com-
parison to sham samples.
experimental Design and statistical 
analysis
Sample sizes were estimated from pilot studies and previous data 
using power analysis or the resource equation method to achieve 
80% power at P < 0.05. Animals were randomized to experimen-
tal groups (e.g., time-point after MCAO, drug treatment) using 
a computer-based random number generator (https://www.ran-
domizer.org/). The assessor was unware of allocation to experi-
mental group during analysis of outcome measures although no 
formal blinding procedures were in place. Data are presented as 
mean ± SEM unless otherwise indicated. For normally distributed 
data, differences were tested using unpaired Student’s t-test or 
analysis of variance (ANOVA) with Bonferroni or Tukey correc-
tion unless otherwise stated. For non-normally distributed data, 
equivalent non-parametric tests were used and results displayed 
as median ± minimum and maximum values. Data were analyzed 
using GraphPad Prism. In all experiments, values of P ≤ 0.05 were 
accepted as statistically significant.
resUlTs
increased Density of Macrophages  
in the rP after experimental stroke
RPM remove senescent erythrocytes from the blood, regulate 
iron metabolism, and contribute to the cytokine microenviron-
ment, which directs adaptive immune responses (19, 23). Given 
the importance of these functions for maintaining red blood cell 
homeostasis, iron recycling and reducing bacterial infection, we 
investigated specific effects of experimental stroke on RPM popu-
lations. Immunofluorescent labeling with F4/80 detects both tis-
sue resident (F4/80hi CD11b−/lo) and monocyte-derived (F4/80+ 
CD11b+) populations of RPM (described above), whereas labeling 
of CD11b detects monocyte-derived (F4/80+ CD11b+) RPM only. 
Both methods of detecting RPM showed an increased density 
of macrophages in the RP from 1 to 7 days after experimental 
stroke (CD11b; blue, F4/80; red, Figure 1A), which is confirmed 
by analysis of the percentage of positive immunofluorescence 
for each marker per image (Figures  1B,C). By 5  days after 
experimental stroke, large clusters of monocyte-derived CD11b+ 
macrophages (CD11b; blue, Figure 1A) were found within the 
WP, whereas in naïve and sham-operated controls, this subset is 
confined to the RP only suggesting a loss of the normal bounda-
ries between RP and WP macrophage subsets. Despite this local 
increase in cell density, flow cytometric analysis showed an overall 
reduction in the absolute number of RPM in spleens 2 days after 
experimental stroke in comparison to sham-operated animals 
(Figures 1D,E). The reduction in cell numbers is most likely due 
to the splenic atrophy and loss of total cellularity known to occur 
after stroke resulting in a local increase in RPM density within 
remaining contracted spleen tissue but no overall increase in cell 
number.
CD11b can be expressed by multiple myeloid cell types, 
therefore to determine the distribution of CD11b immunolabel-
ling on splenocytes, we assessed co-localization of CD11b with 
F4/80, Ly6C (expressed on monocytes and granulocytes) Ly6G 
(expressed specifically by neutrophils) and with the antibody 
SJC4 (neutrophil-specific polyclonal antibody). F4/80+CD11b+ 
cells representing the monocyte-derived RPM were detected but 
F4/80–CD11b+ cells were also present in the RP indicating that 
not all of the CD11b+ cells were RPM (Figure 1F). Some CD11b+ 
cells co-localized with Ly6C, LygG, and SJC4 suggesting that the 
F4/80−CD11b+ cells in the RP were comprised of monocytes and 
neutrophils (Figure 1F). To determine if the increased density of 
CD11b+ cells demonstrated previously (Figures 1A,B) was due 
to an increase in immunolabelling of neutrophils, we examined 
CD11b and SJC4 co-localization after experimental stroke 
(Figure 1G). The percentage of CD11b+SJC4+ co-localization was 
not significantly altered after experimental stroke in comparison 
to naïve or sham-operated animals (Figures 1G,H). As the area 
of CD11b+ immunolabelling is increased after stroke (Figure 1B) 
and percentage of CD11b+SJC4+ co-localization remains 
unchanged, it can be concluded that the density of F4/80+CD11b+ 
monocyte-derived RPM does indeed increase after experimental 
stroke, and there is a proportional increase in CD11b+SJC4+ 
neutrophils also. CD11b is also expressed by subpopulations 
of DC in the spleen including TNF/iNOS producing (Tip) DC, 
monocyte-derived (mo) DC, L-DC, and expressed at low levels 
by conventional CD8− DC (43, 44). Immunolabelling for CD11c, 
which is expressed by the majority of DC subsets including 
CD8− DC (43), was quantified and is unaffected by experimental 
stroke (Figures  2A,H). Additionally, the proportion of CCR2-
RFP+ CD11b+ cells remains unchanged by experimental stroke 
(Figure 3D) meaning it is unlikely that TipDC and moDC, which 
are both derived from recruited monocytes under conditions of 
inflammation contribute to increased CD11b+ cells in the spleen 
after stroke. L-DC make up less than 3% of the total myeloid/
DC pool in the spleen (44). Therefore although we have not 
specifically assessed the contribution of CD11b+ DC subsets in 
this study, these subsets are unlikely to be major contributors to 
the increased CD11b density seen after experimental stroke.
As number, density, and location of RPM were affected by 
experimental stroke, we next determined expression levels of genes 
of interest important for RPM-mediated antibacterial defense 
from microarray data obtained from spleens from sham-operated 
animals or animals recovered 1, 2, or 5 days after experimental 
stroke. CD163, a scavenger receptor that is highly expressed on 
RPM relative to other macrophage subsets, allows the clearance 
FigUre 1 | Increased density of macrophages in the red pulp (RP) after experimental stroke. (a) Immunofluorescent labeling of monocyte-derived RPM (blue, 
CD11b) or both tissue resident and monocyte-derived RPM (red, F4/80) in the splenic RP from naïve mice, mice recovered 1 to 7 days after middle cerebral artery 
occlusion (MCAO) or sham-operated mice. Quantification of immunolabelling shows increased percentage area of CD11b (b) and F4/80 (c) immunolabelling 
per section in mice 1–5 days or 1–7 days, respectively, after experimental stroke in comparison to sham-operated or naïve controls (naïve n = 4, sham n = 4,  
1 day n = 4, 2 days n = 9, 5 days n = 5, 7 days n = 7). Flow cytometry analysis of the spleen shows that the absolute number of (D) CD11b+ and (e) F4/80+ cells  
is reduced 2 days after stroke in comparison to sham-operated animals (sham n = 4, MCAO n = 6). (F) Immunofluorescent labeling of CD11b (blue) alongside 
markers for macrophages (red, F4/80), monocytes (red, Ly6C), and neutrophils (red Ly6G; SJC4) in spleens from mice recovered 2 days after MCAO (n = 4).  
(g) Immunofluorescent labeling of CD11b (blue) and SJC4 (red) in the splenic RP from naïve mice, mice recovered 1 to 7 days after MCAO or sham-operated  
mice. (h) Quantification of CD11b and SJC4 shows the percentage of CD11b+ immunolabelling that co-localizes with SJC4 is not significantly altered 1–7 days  
after MCAO (naïve n = 4, sham n = 4, 1 day n = 4, 2 days n = 9, 5 days n = 5, 7 days n = 7). Analysis of spleen microarray data shows significantly increased 
transcription of Cd163 (i) at 1–5 days and Lipocalin2 (K) at 2 days after MCAO in comparison to sham-operated controls (sham n = 2, 1 day and 2 days n = 3, 
5 days n = 4). (J) RT-qPCR analysis confirmed a trend for upregulation of Cd163 mRNA after experimental stroke. (l) RT-qPCR analysis of Lcn2 mRNA confirmed 
upregulation at 2–5 days after MCAO in comparison to sham operated animals (naïve n = 4, sham n = 4, 1 day n = 4, 2 days n = 9, 5 days n = 5, 7 days n = 7). 
Scale bars (a) 200 µm, (F,g) 100 µm. Data show mean ± SD (b,c,h–l) *P < 0.05; **P < 0.01; ***P < 0.05 one-way analysis of variance with Bonferonni correction; 
(D,e) unpaired t-test.
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of hemoglobin released from damaged erythrocytes (23, 45). 
RPM additionally express Lipocalin 2, which binds the bacterial 
siderophores pathogens use to scavenge iron. Sequestration of 
siderophores is important mechanism in preventing bacterial 
growth and reducing infection (46). Lipocalin2 can also be 
expressed by neutrophils, which may additionally contribute 
to splenic antibacterial defenses. Microarray analysis showed 
increased expression of transcripts for Cd163 (Figure  1I) and 
Lcn2 (Lipocalin2; Figure 1K) 1–5 days after experimental stroke 
in comparison to sham-operated controls. RT-qPCR analysis of 
mRNA showed a trend for increased CD163 expression after 
experimental stroke although this was not statistically significant 
(Figure  1J). RT-qPCR analysis of Lcn2 confirmed significant 
upregulation at 2–5 days after experimental stroke in compari-
son to sham (Figure 1L). RPM-associated genes are upregulated 
despite the significant overall reduction in numbers of RPM. 
Increased local density of neutrophils after experimental stroke 
may further contribute to this retained antibacterial defense 
mechanism.
experimental stroke Differentially affects 
MZ and WP Macrophage Populations
The highly organized structure of the spleen and the positioning of 
macrophage sub-populations in distinct micro-anatomical loca-
tions are crucial to enable their distinct but complementary roles 
in antibacterial defense, pathogen/apoptotic cell clearance, and 
regulation of adaptive immune responses (18, 29, 31, 34, 35, 38, 39). 
Experimental stroke induced an increase in MZM immunolabel-
ling (MARCO; green, Figure 2A) indicating an increased cellular 
density. This resulted in a significant thickening of the width of 
the MZM border measured at 1–5 days after experimental stroke 
(Figure 2C). In contrast, MMM remained unaffected (MOMA-1; 
red, Figures  2A,D). Similarly to RPM, absolute numbers of 
FigUre 2 | Continued
7
McCulloch et al. Stroke-Induced Effects on Splenic Macrophages
Frontiers in Immunology | www.frontiersin.org May 2018 | Volume 9 | Article 1108
FigUre 2 | Experimental stroke differentially affects marginal zone (MZ) and white pulp (WP) macrophage populations. (a) Immunofluorescent labeling of spleens 
from mice recovered 1–7 days after middle cerebral artery occlusion (MCAO) for marginal zone macrophages (MZM) (green, MARCO), marginal zone metallophillic 
macrophages (red, MOMA-1), tingible body macrophages (red, MOMA-2 within WP), classical dendritic cells (blue, CD11c), and DEC205+ DC (red, DEC205).  
(b) Measuring the width of MARCO+ immunolabelling in the MZ confirms expansion of the MZM population 1–5 days after experimental stroke whereas the width of 
the MOMA-1+ MZ metallophillic macrophage border (c) remains unchanged. Flow cytometry analysis of the spleen shows that the absolute number of (D) MARCO+ 
and (e) MOMA-1+ cells are reduced 2 days after stroke in comparison to sham-operated animals (sham n = 4, MCAO n = 6). (F) Immunofluorescent labeling of 
spleens with CD68 (red) alongside B cells (B220, green) confirms a similar pattern of immunostaining in the WP as MOMA-2 (red) immunolabelling (naïve n = 4, 
sham n = 4, 1 day n = 4, 2 days n = 9, 5 days n = 5, 7 days n = 7). (g) Quantification of the percentage of MOMA-2+ tingible body macrophage immunolabelling in 
the WP confirms significant increases in MOMA-2+ immunolabelling 5 days after experimental stroke in comparison to sham-operated controls. (h) The percentage 
area of CD11c+ immunolabelling is unchanged after experimental stroke in comparison to sham-operated animals. (i) A significant increase in the percentage of 
DEC205+ immunolabelling per section can be seen 2–5 days after experimental stroke in comparison to sham-operated controls (naïve n = 4, sham n = 4, 1 day 
n = 4, 2 days n = 9, 5 days n = 5, 7 days n = 7). Scale bars 100 µm. Data show mean ± SD *P < 0.05; **P < 0.01; ***P < 0.005; (b,c,g–i) one-way analysis of 
variance with Bonferonni correction. (D,e) unpaired t-test.
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MARCO+ and MOMA-1+ macrophage subsets were reduced 
2 days after experimental stroke in comparison to sham-operated 
animals (Figures 2E,F). TBM can be identified by their distinct 
morphology, large cells with tingible bodies within the cytoplasm, 
and their location within the follicle. MOMA-2+ immunolabelling 
was measured within the WP only to specifically detect TBM and 
showed increased TBM immunolabelling at 5 days after experi-
mental stroke (MOMA-2; red, Figures 2A,G). Immunolabelling 
of CD68 and B220 on serial sections was used to confirm TBM 
immunolabelling which are CD68+ and located within the B cell 
follicle (Figure 2B). CD68 immunolabelling occurred in a similar 
pattern to MOMA-2 immunolabelling within the WP provid-
ing further support that these were indeed TBM (Figure  2F) 
(47, 48). No difference in the amount of CD11c+ immunolabel-
ling was identified (Figure 2H). However, CD11c+ DC which are 
normally enriched in the periarteriolar lymphoid sheath (PALS) 
area of the WP and the MZ, became dispersed throughout WP 
at 2 and 5  days after experimental stroke with no particular 
microanatomical localization (CD11c, blue, Figure 2A). This is in 
accordance with previous reports on loss of distinction between B 
and T cell areas within the splenic WP after experimental stroke 
(8). An increase in immunolabelling of DEC205+ DC was seen in 
both the MZ and WP at 1–7 days after experimental stroke and 
was confirmed by quantification of immunolabelling (Figure 2I). 
Overall, these data and analysis of RPM populations (Figure 1) 
demonstrate that distinct subpopulations of splenic macrophages 
are differentially affected by experimental stroke in terms of their 
distribution and localization within the spleen.
increased cellular Density of splenic 
Macrophage subsets is not Due to 
increased recruitment From bone Marrow
After experimental stroke, spleen size is reduced due to an overall 
loss of cellularity and contraction of the organ (8, 10, 14, 16). There 
is an extensive depletion of lymphocytes and remaining cells are 
no longer organized into their distinct microanatomical compart-
ments, crucial for effective immune function (8, 10). In contrast, 
despite overall reductions in numbers, we have shown mac-
rophage populations are maintained within their immunological 
niches and some subsets show local increases in density. Under 
homeostatic conditions, splenic macrophages are maintained by 
both local proliferation, and to a lesser extent, replenished from 
bone marrow-derived monocytes (22). However, in conditions 
of inflammation or cellular depletion, both mechanisms can be 
used to replenish or indeed augment tissue-resident populations 
(22). Understanding the origin of locally increased macrophage 
sub-populations is important so that therapeutic strategies 
affecting macrophages can be optimally designed to reduce 
susceptibility to stroke-associated infection. Ccr2RFP/+ mice have 
the sequence for red fluorescent protein (RFP) knocked into the 
locus encoding CCR2 at a heterozygous level resulting in expres-
sion of RFP in CCR2 expressing cells but retaining normal CCR2 
function (41). Upregulation of CCR2 is important for immune 
cell efflux from the bone marrow and recruitment to sites of 
inflammation; therefore, RFP+ cells in the spleen represent those 
recently recruited from the bone marrow (49, 50). Analysis of 
RFP expression in sham-operated animals indicated a contribu-
tion of bone marrow-derived cells within the RP, WP, and MZ 
that remained relatively unchanged 2  days after experimental 
stroke (Figure 3A). Within the spleen, lymphocytes, NK cells, 
and neutrophils can express CCR2 under homeostatic condi-
tions, in addition to expression on monocytes/macrophages and 
DC (51). Flow cytometry was used to determine the percentage 
of CCR2+ cells within macrophage subpopulations to determine 
the contribution of infiltrating bone marrow-derived monocytes 
to this expansion. Flow cytometry confirmed there was no 
increase in the percentage of RFP-expressing MOMA-1+ MMM 
(Figure 3B), MARCO+ MZM (Figure 3C), CD11b+ (monocyte-
derived) RPM (Figure  3D) or F4/80+ (monocyte-derived and 
tissue-resident) RPM (Figure  3E) populations suggesting that 
the homeostatic rate of replacement of these cells from bone mar-
row-derived monocytes is not altered by experimental stroke. We 
demonstrated above increased local densities of tissue-resident 
and monocyte-derived RPM and MZM after experimental stroke 
(see Figures 1 and 2); however, there is no increased presence 
of RFP+ cells above baseline turnover within these populations 
(Figures 3A,C). Identification of actively proliferating cells using 
KI-67 immunolabelling showed increased KI-67 staining associ-
ated with MARCO+ macrophages and F4/80+ RPM (Figure 3F). 
Additionally, large KI-67+ cells were observed in the WP con-
sistent with the location and morphology of TBM (Figure 3F). 
Taken together, these data suggest that, after experimental stroke, 
there is no change in the numbers of bone marrow-derived 
monocytes recruited to the spleen above normal homeostatic 
turnover. Increased labeling of KI-67 in F4/80+ RPM, MARCO+ 
FigUre 3 | Increased density of splenic macrophage subsets is not due to increased recruitment from bone marrow. (a) Spleen sections from naïve CCR2RFP/+ mice or 
CCR2RFP/+ recovered 2 days after MCAO to determine number and location CCR2+ (red; RFP) cells infiltrating from bone marrow (naïve n = 4, MCAO + 2 days n = 4). Flow 
cytometric analysis of spleens from CCR2RFP/+ mice shows no difference in the percentage of (b) MOMA-1+; (c) MARCO+; (D); CD11b+; or (e) F4/80+ cells expressing 
RFP in mice recovered 2 days after MCAO in comparison to sham-operated animals (sham n = 4, MCAO n = 6). (F) Increased immunofluorescent labeling of proliferation 
markers (white, KI-67) associated with MARCO+ marginal zone macrophages (green, MARCO) or red pulp macrophages (red, F4/80) in the spleens of mice recovered 
2 days after MCAO in comparison to sham-operated animals (sham n = 4, MCAO n = 4). Scale bars (a) 100 µm, (F) 50 µm. Data show mean ± SD; unpaired t-test.
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MZM, and TBM in the WP suggests that these increases may be 
associated with local proliferation.
Macrophage subpopulation-specific 
increases in Markers of lysosome activity 
after experimental stroke
Phagocytosis of pathogens and senescent cells is a crucial role of 
many splenic macrophage subsets. Analysis of microarray data 
from spleen tissue collected 1, 2, or 5 days after experimental stroke 
was used to assess expression of families of functionally related 
genes associated with these processes after experimental stroke. 
LAMP 1 and 2 are expressed on the membrane of lysosomes and 
are thought to be important in maintaining lysosomal integrity, 
pH, and catabolism (52). Splenic expression of Lamp2 but not 
Lamp1 was increased after experimental stroke (Figure  4A) 
and analysis of mRNA levels by RT-qPCR confirmed significant 
upregulation of Lamp2 2 days after experimental stroke in com-
parison to sham surgery (Figure 4B). To determine the splenic 
macrophage subsets affected, we analyzed co-localization of 
splenic LAMP2 immunolabelling alongside macrophage subset-
specific markers. Co-localization of LAMP2 immunolabelling 
with most macrophage subsets was observed to some extent 
in naïve and sham-operated animals. However, image analysis 
showed LAMP2 co-localization was significantly increased in 
both F4/80hi CD11b−/lo and F4/80+ CD11b+ subsets of RPM 
(Figures 4C–E) and MARCO+ MZM (Figures 4C,F) 2 days after 
experimental stroke. In accordance with the function of TBM in 
the clearance of apoptotic cells from the follicle, high levels of 
LAMP2+ immunolabelling co-localized with MOMA-2+ cells in 
the WP of naïve and sham-operated animals and a small increase 
was detected 2  days after experimental stroke (Figures  4C,H). 
In contrast, LAMP2 expression by MOMA-1+ MMM remained 
relatively unchanged (Figures 4C,G).
After phagocytosis, proteins are processed into peptides by 
endo/lysosomal cysteine and aspartate proteases. The protease cath-
epsin L is specifically involved in generation of peptides for antigen 
presentation within the mouse spleen (53). An upregulation of tran-
script for cathepsins, including Cathepsin L (Ctsl) and Legumain 
(Lgmn) was seen in spleens 1–5 days after experimental stroke in 
comparison to sham-operated controls (Figure 4I) and increased 
expression of Ctsl mRNA was confirmed by RT-qPCR suggesting 
there was no impairment in proteolytic processing of endocytosed 
material in the spleen after experimental stroke (Figure 4J).
FigUre 4 | Macrophage subpopulation-specific increases in markers of lysosome activity after experimental stroke. (a) Analysis of transcripts of genes associated 
with lysosome formation show that lysosomal-associated membrane protein 2 (Lamp2) expression is upregulated after stroke, whereas Lamp1 remains relatively 
unchanged (sham n = 2, 1 day and 2 days n = 3, 5 days n = 4). (b) RT-qPCR for Lamp2 confirmed significant upregulation of expression 2 days after middle 
cerebral artery occlusion (MCAO) in comparison to sham-operated animals (naïve n = 4, sham n = 4, 1 day n = 4, 2 days n = 9, 5 days n = 5, 7 days n = 7).  
(c) Immunofluorescent labeling of LAMP2 (green, LAMP2) along with labeling for both tissue resident and monocyte-derived RPM (blue, F4/80; top panel) marginal 
zone macrophages (magenta, MARCO; top panel), marginal zone metallophillic macrophages (red, MOMA-1; middle panel), monocyte-derived RPM only  
(blue, CD11b; middle panel), or tingible body macrophages (red, MOMA-2 within the WP; bottom panel) in spleens from naïve mice, or mice recovered 1–7 days 
after MCAO or sham surgery (naïve n = 4, sham n = 4, 1 day n = 4, 2 days n = 9, 5 days n = 5, 7 days n = 7). Quantification of co-localization of LAMP-2 
immunolabelling with macrophage subset markers showed increased expression of LAMP2 associated with (D) F4/80+ tissue resident and monocyte-derived RPM, 
(e) CD11b+ monocyte-derived RPM alone and (F) MARCO+ MZM at 2–5 days after MCAO in comparison to sham-operated animals. (g) However co-localization 
remained unchanged on MOMA-1+ marginal zone metallophillic macrophages (h) Co-localization of MOMA-2+ immunolabelling with LAMP-2 was high at baseline in 
naïve and sham-operated animals and was only significantly upregulated at 5 days after MCAO (naïve n = 4, sham n = 4, 1 day n = 4, 2 days n = 9, 5 days n = 5, 
7 days n = 7). (i) Expression of protease transcripts show most proteases are modestly upregulated after MCAO; however, expression of Ctsl, which encodes 
Cathepsin L1, is highly upregulated 1–5 days after experimental stroke in comparison to sham-operated animals (sham n = 2, 1 day and 2 days n = 3, 5 days 
n = 4). (J) RT-qPCR for Ctsl confirmed upregulation of expression 2–5 days after MCAO in comparison to sham-operated animals (naïve n = 4, sham n = 4,  
1 day n = 4, 2 days n = 9, 5 days n = 5, 7 days n = 7). Scale bars (c) top panel, middle panel 200 µm; (c) bottom panel 100 µm. Data show mean ± SD 
(b,D–h,J) *P < 0.05; ***P < 0.005; one-way analysis of variance with Bonferonni correction.
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These data show upregulation of genes encoding proteins 
invo lved in lysosome function and proteolytic processing after 
experimental stroke and a subset-specific increase in a key marker 
of macrophage lysosome activity was confirmed by immunohis-
tochemical labeling of LAMP2 in both tissue-resident and bone 
marrow-derived RPM and MZM. This suggests that there are no 
impairments in these processes, which are crucial for efficient 
phagocytosis, in the spleen due to experimental stroke.
MZM efficiently Traffic antigen From  
the circulation to the Follicle
The transport of intact protein antigen from the MZ to the FDC 
network is crucial to aid the generation of high affinity antibody 
production by B cells (54, 55). Given the increased expression of 
genes associated with lysosome activity and proteolytic process-
ing and the increased LAMP2 staining in MZM (see Figure 4), 
we next determined if there were any impairments in antigen traf-
ficking from the MZ to the WP after experimental stroke. Spleens 
were harvested 1 h after injection of fluorescently labeled dextran 
to determine initial trapping in the MZ and at 24 h after injec-
tion to determine subsequent trafficking to the follicle. Increased 
capture of Dextran-FITC associated with MARCO+ MZM was 
observed 2  days after experimental stroke in comparison to 
sham-operated and naïve controls (Figures  5A,B). This could 
relate to the increased density of MARCO+ MZM present after 
experimental stroke (Figures 2A,B). At this time point, only low 
levels of Dextran-FITC were detected in the WP, and this was 
similar across all groups (Figures 5A,B). At 24 h after injection, 
antigen was efficiently transported into the follicle and levels were 
similar across all groups (Figures 5A,C). These data indicate the 
trafficking of intact antigen is not impaired by the increased 
endosomal and proteolytic activity detected in MARCO+ MZM 
after experimental stroke. This implies the ability of macrophages 
FigUre 5 | Marginal zone macrophages (MZM) efficiently traffic antigen from the circulation to the follicle. (a) Fluorescently labeled model antigen (green, 
Dextran-FITC) is trapped in the spleen by MZM (red, MARCO) in spleens from animals recovered 2 days from middle cerebral artery occlusion (MCAO) or sham 
surgery or naïve controls 1 h after iv injection. By 24-h post iv injection, antigen has been trafficked into the follicle of the white pulp (WP). Naïve animals were 
injected with vehicle (PBS) as a control. Quantification of the percentage area of Dextran-FITC associated with the marginal zone (MZ) or WP of the spleen at 1 h  
(b) and 24 h (c) shows increased trapping of antigen in the MZ at 1 h and no impairments in antigen trafficking to the follicle at 24 h in mice 2 days after MCAO in 
comparison to sham or naïve controls (for each time point naïve n = 4, sham n = 2, MCAO n = 4, naïve + PBS n = 2). Scale bar 50 µm. Data show mean ± SD 
(b,c), **P < 0.01; one-way analysis of variance with Bonferonni correction.
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specialized to capture and traffic antigen to the FDC network and 
facilitate the GC response is not impaired by experimental stroke.
Macrophage subpopulation-specific 
impairments in expression of Mhc class ii
Previous studies have reported reduced expression of MHC 
class II on human blood monocytes and mouse splenocytes after 
stroke, which demonstrates a reduced activation status and an 
inability to present antigen to aid adaptive immune responses (11, 
12, 56, 57). However, it is currently unknown if all macrophage 
subsets are equally affected. Analysis of microarray data was used 
to assess expression of genes related to MHC class II expression, 
stability and peptide loading. This analysis demonstrated reduced 
expression of the H2 genes, H2-Aa, H2-Ab1, H2-Eb1, H2-Eb2, 
H2-M2, H2-M3, H2-Oa, and H2-Ob, responsible for MHC Class 
II expression in comparison to spleens from sham-operated 
animals (Figure 6A). Furthermore, expression of genes encoding 
proteins involved in stabilization of MHC Class II molecules, the 
MHC Class II invariant chain (Cd74; Figure 6A), and loading of 
peptide for antigen presentation (HLA-DM; Figure 6A) were also 
downregulated after experimental stroke. To determine if reduced 
expression of MHC Class II could be associated with specific 
splenic macrophage subsets, MHC Class II immunolabelling was 
performed alongside various macrophage subpopulation markers 
and the percentage of each subset marker that co-localized with 
MCH class II immunolabelling was quantified. This demonstrated 
MHC class II expression by MOMA2+ TBM (red, Figures 6B,C) 
within the WP was unchanged after experimental stroke. A small 
increase in MHC class II co-localization with CD11c+ classical 
DC immunolabelling was detected at 2 days post experimental 
stroke but remained unchanged at all other time points (blue; 
Figures 6B,D). Low levels of co-localization of MHC Class II with 
MOMA1+ MZM was detected in spleens from sham and naïve 
animals and again this was unchanged in response to experimen-
tal stroke (red Figures 6B,E). However, expression of MHC Class 
II on MARCO+ MZM (red; top panel, Figures 6B,F) and both 
populations of RPM (F4/80; blue, CD11b; blue; Figures 6B,G–H) 
appeared reduced 1–7 days after experimental stroke. MHC Class 
II immunofluorescence within the WP that is not co-localized 
with any macrophage marker was also reduced after experimental 
stroke. This most likely represents MHC Class II+ B cells which we 
have previously shown to be severely depleted after experimental 
stroke (8). These data suggest that impairments in the expres-
sion of MHC Class II specifically occurs in RPM and MZM after 
experimental stroke, whereas other subsets such as TBM, DC, 
and MMM remain unaffected.
reduced splenic expression of genes 
required for Macrophage response to 
Pathogens
Functional deactivation of monocytes/macrophages after stroke 
is thought to contribute to SAI with deficits reported in activation 
FigUre 6 | Macrophage subpopulation-specific impairments in expression of MHC Class II. Genome-wide transcriptional analysis was performed by microarray of 
RNA extracted from spleen tissue of mice recovered 1, 2, or 5 days after middle cerebral artery occlusion (MCAO) or sham surgery. The fold-change of 
macrophage-associated gene expression levels was analyzed in relation to expression measured in spleens from sham-operated animals (a) Analysis of the H2 
genes which encode mouse MHC class II show downregulation of expression of all H2 genes 1–5 days after MCAO in comparison to sham-operated animals (sham 
n = 2, 1 day and 2 days n = 3, 5 days n = 4). (b) MHC Class II (green) immunolabelling along with labeling for marginal zone macrophages (MZM) (red, MARCO; top 
panel), both tissue resident and monocyte-derived RPM (blue, F4/80 top panel), tingible body macrophages (red, MOMA-2 within white pulp; middle panel), classical 
dendritic cells (blue, CD11c middle panel), marginal zone metallophillic macrophages (red, MOMA-1; bottom panel) or monocyte-derived RPM only (blue, CD11b; 
bottom panel) to determine co-localization of MHC Class II on splenic macrophage subsets. Image analysis determined the percentage of (c) MOMA-2, (D) CD11c, 
(e) MOMA-1, (F) MARCO, (g) F4/80, and (h) CD11b immunolabelling that co-localized with MHC class II immunolabelling 1–7 days after MCAO in comparison to 
sham-operated or naïve controls (naïve n = 4, sham n = 4, 1 day n = 4, 2 days n = 9, 5 days n = 5, 7 days n = 7). Scale bars 100 µm. Data show mean ± SD 
*P < 0.05; ***P < 0.005; (c–h) one-way analysis of variance with Bonferonni correction.
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of adaptive immune responses and production of inflammatory 
cytokines (11, 12, 56–58). Transcriptional analysis showed a 
reduction in the expression of toll-like receptor (TLR) genes 
(Figure 7A), and this finding was validated for Tlr1 by RT-qPCR 
(Figure  7B). Many splenic cell populations can express TLR 
however cells of the innate immune system are reported to 
express a broader range of TLR than that of the adaptive immune 
system (59). These data suggest there is a reduced ability to 
detect pathogens through TLR ligation in the spleen after stroke 
which may impact macrophage ability to detect and respond to 
pathogen.
Human blood monocytes and mouse splenocytes have also 
been reported to be less capable of providing co-stimulatory sig-
nals required for activating T cells after stroke (56, 57). However 
as of yet, expression of costimulatory genes or proteins on mac-
rophages after stroke has not yet been assessed. Transcriptional 
analysis confirmed a reduction in expression of co-stimulatory 
genes in the spleen known to be expressed by macrophages 1–5 
days after experimental stroke including Cd40, Cd80, Cd86, 
Icam1, Tnfsf9, which encodes 4-1BBL, and Cd274 (Figure 7C). 
RT-qPCR analysis of Cd40 mRNA validated these transcriptional 
findings (Figure  7D). The functional deactivation of human 
blood monocytes has been further described by reduced produc-
tion of the cytokine TNFα after stimulation which is thought 
to be due to increased circulating IL-10 concentrations (10, 11, 
58, 60). Transcript levels of Tnfa were also reduced in the spleens 
of mice 1–5  days after experimental stroke in comparison to 
sham-operated controls whereas Il-10 transcript was margin-
ally increased above baseline (Figure  7E). RT-qPCR analysis 
validated reduced Tnfa mRNA 1–7 days after experimental stroke 
(Figure 7F) and levels of TNFα protein were suppressed 1–5 days 
after experimental stroke using a cytometric bead array on spleen 
homogenate (Figure 7G).
Overall, these data suggest that the effects of experimental 
stroke are restricted to RPM populations and MZM specifically 
whereas other macrophage populations remain unaffected. These 
FigUre 7 | Reduced splenic expression of genes required for macrophage response to pathogens. (a) Analysis of toll-like receptor (TLR) transcripts show 
downregulated expression of the majority of tlr genes 1–5 days after middle cerebral artery occlusion (MCAO) in comparison to sham-operated animals  
(sham n = 2, 1 day and 2 days n = 3, 5 days n = 4). (b) RT-qPCR for Tlr1 confirmed significant downregulation at 2–5 days after MCAO in comparison to 
sham-operated animals (naïve n = 4, sham n = 4, 1 day n = 4, 2 days n = 9, 5 days n = 5, 7 days n = 7). (c) Expression of transcripts which encode 
macrophage-associated co-stimulatory proteins important for activating the adaptive immune response show downregulated expression 1–5 days after MCAO 
in comparison to sham-operated animals (sham n = 2, 1 day and 2 days n = 3, 5 days n = 4). (D) RT-qPCR for Cd40 confirmed significant downregulation at 
2–5 days after MCAO in comparison to sham-operated animals (naïve n = 4, sham n = 4, 1 day n = 4, 2 days n = 9, 5 days n = 5, 7 days n = 7).  
(e) Expression of Tnfa which encodes the cytokine TNFα was downregulated 1–5 days after experimental stroke whereas expression of Il-10 which encodes 
the cytokine IL-10 remained relatively unchanged (sham n = 2, 1 day and 2 days n = 3, 5 days n = 4). (F) RT-qPCR for Tnfa confirmed downregulation of 
expression 1–7 days after MCAO in comparison to sham-operated animals (naïve n = 4, sham n = 4, 1 day n = 4, 2 days n = 9, 5 days n = 5, 7 days n = 7). 
(g) CBA assay of homogenized spleen detected TNFα in the spleens of sham-operated animals and animals recovered 7 days after MCAO; however, this was 
undetectable in spleens from mice recovered 1–5 days after MCAO. Data show mean ± SD (b,D,F), *P < 0.05; **P < 0.01; one-way analysis of variance with 
Bonferonni correction.
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subsets are shown to be locally increased and associated with 
increased expression of lysosomal protein (LAMP2) indicative 
of increased phagocytic activity. Despite increased expression of 
genes associated with lysosome activity and proteolytic process-
ing of protein, these same macrophage subsets have a reduced 
ability to stably produce and express MHC Class II. Further 
transcriptional data shows reduced splenic expression of genes 
associated with pathogen sensing and co-stimulation and reduced 
production of the pro-inflammatory cytokine TNFα. Taken 
together, these impairments may contribute to a reduced ability to 
clear pathogens after stroke and an increased susceptibility to SAI.
DiscUssiOn
The data presented here demonstrate that experimental stroke has 
differential effects on subpopulations of splenic macrophages that 
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are distinct in function, origin and micro-anatomical location. 
Key findings demonstrate that after experimental stroke in mice:
 (1) At a micro-anatomical level, there is increased density of 
specific subsets of splenic macrophages including both 
tissue-resident and bone marrow-derived populations of 
RPM and MZM, whereas other subsets remain unchanged.
 (2) These increases are not due to increased recruitment of cells 
from the bone marrow but may be associated with increased 
local proliferation of cells within a contracted spleen size.
 (3) Macrophage transport of antigen from MZ to follicle is unaf-
fected by these changes.
 (4) RPM and MZM selectively show increased evidence of 
phagocytosis via increased LAMP2 expression but reduced 
ability to present antigen as determined by reduced expres-
sion of MHC Class II.
Thus, there is evidence to support subset-selective changes 
to splenic macrophages after experimental stroke that may con-
tribute to susceptibility to SAI. Furthermore, we demonstrated 
reduced expression of genes in the spleen relating to sensing of 
pathogens, co-stimulation of adaptive immune responses and 
production of the pro-inflammatory cytokine TNFα, which may 
additionally contribute to impaired anti-bacterial activity after 
stroke.
The organization of cells into defined micro-anatomical 
comp artments within the spleen is crucial to allow it to carry 
out its immunological functions effectively (18, 34). Highly 
adapted sub-populations of macrophages in distinct compart-
ments within the spleen are of variable origin and function but 
contribute in complementary ways to ensure maintenance of 
normal homeostasis and efficient protection from infection 
(61). We have shown differential effects on these subpopulations 
after experimental stroke. Although there is an overall reduc-
tion in spleen size and cellularity after experimental stroke, 
both populations of RPM were increased in density within the 
remaining contracted tissue, and we observed CD11b+ mac-
rophages normally restricted to the RP appear within the WP 
after experimental stroke (Figures 1A–C).
Within the MZ, MZM increased in density and there were 
more DEC205+ DC present, but there was no apparent change 
to MMM (Figures  2A,C,F). In the WP, TBM immunolabel-
ling was increased, but no change in DC density was detected, 
although their localization was altered (Figures  2A,D,E). It 
is important to understand stroke induced changes to mac-
rophage subpopulations in the context of their surrounding 
immune environment as the structural organization facilitates 
communication between immune cells and allows efficient 
responses to be generated. However, the limitations of this 
approach mean that it can be difficult to further dissect precise 
mechanisms responsible for inducing these changes on specific 
subpopulations of macrophages and their functional conse-
quences on infection susceptibility in relation to the contribu-
tion of other immune cells. We now know there are multiple 
stimuli present in the spleen after experimental stroke that may 
contribute to producing these subpopulation specific effects 
on splenic macrophages, including but not limited to systemic 
infection, increased levels of stress-associated mediators such 
as noradrenaline and cortisol (11, 62), and large numbers of 
apoptotic cells (8). In agreement to our observations on splenic 
macrophage phagocytosis, in vitro exposure of healthy human 
monocytes to catecholamines, glucocorticoids, or acetylcholine 
has been shown to have no adverse effects on phagocytosis 
(63). However, catecholamines and glucocorticoids reduced 
the ability of monocytes and granulocytes to undergo oxidative 
burst, a crucial mechanism to clear bacteria internalized by 
phagocytosis (63). It has also been reported that catecholamines 
and glucocorticoids reduce NETosis in human neutrophils (64). 
Understanding which of the multiple stimuli present in the 
spleen after stroke triggers the responses we see in individual 
splenic macrophage subpopulations, and why only some popu-
lations respond to these, remains to be investigated and may 
improve our ability to therapeutically target macrophages to 
improve stroke outcome.
Spleen macrophages are crucial for the recognition and clear-
ance of pathogens in the circulation (27–29, 34). We observed 
reduced expression of genes in the spleen associated with 
macro phage activation status (MHC Class II; Figure 6A) and 
pathogen recognition ability (TLRs Figure  7A), suggesting 
there may be impairments in the detection of pathogens by TLRs 
and subsequent activation induced by their ligation. However, 
recognition of bacterial glycans by macrophage-expressed 
lectins appears unaffected as indicated by efficient trapping of 
the model antigen dextran in the MZ after experimental stroke 
(Figure  5) and our previous reports that expression of the 
C-type lectin SIGN-R1 by MZM is unaffected by experimental 
stroke (8). In contrast to reductions in genes associated with 
macrophage activation, expression of genes associated with 
phagocytosis through lysosomes, Lamp2 (Figure 4A), and pro-
teolytic processing of phagocytosed material, Ctsl (Figure 4I) 
were upregulated after experimental stroke suggesting that 
mechanisms necessary for subsequent phagocytic clearance of 
pathogens may be unaffected by stroke.
Increased expression of LAMP2 immunolabelling was spe-
cifically associated with RPM and MZM but remained relatively 
unchanged in MMM (Figures 4C–G) showing a subset-specific 
increase in lysosome activity after experimental stroke. This 
suggests increases in levels of phagocytosis; however, it remains 
to be investigated if this is sufficient to clear pathogens and high 
levels of apoptotic cells present in the spleen after experimental 
stroke without further detrimental effects. In models of sickle 
cell anemia, excessive ingestion of erythrocytes led to deficits 
in macrophage antibacterial function; therefore, it is possible 
that excessive clearance of apoptotic lymphocytes after experi-
mental stroke could induce similar impairments in splenic 
macrophage ability to clear pathogens (65). Furthermore, 
inefficient clearance of apoptotic cells is known to contribute to 
systemic autoimmune disease in humans and mice (36, 66–68). 
TBM in the follicle are important for phagocytosing apoptotic 
lymphocytes from the GC reaction and consistent with this 
showed high levels of LAMP2 immunolabelling in naïve and 
sham-operated animals, which was marginally increased by 
experimental stroke (Figure 4H). However, macrophages in the 
MZ are additionally important in the clearance of apoptotic cells 
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and the suppression of autoimmune responses to these (31, 35). 
In the absence of MZ macrophages, clearance is carried out by 
TBM and RPM with associated increases in pro-inflammatory 
cytokine production and incidence of autoimmune disease (31). 
After experimental stroke, we observed increased expression of 
the lysosomal marker, LAMP2, associated with RPM and MZM 
(Figures  4D–H) and the presence of CD11b+ macrophages 
within the WP (Figure  1A). This may imply that MZ mac-
rophages and TBM alone are unable to clear the high numbers 
of apoptotic cells present in the spleen after experimental stroke 
resulting in local increases in RPM and MZM with increased 
phagocytic activity. As disruption of subset-specific splenic 
macrophage function has been related to aberrant regula-
tion of adaptive immune responses and autoimmune disease 
(19, 21, 31, 36), it remains to be investigated whether the effects 
of experimental stroke on splenic macrophages results in similar 
long-term immune dysregulation.
Macrophages can recruit and activate both innate and adap-
tive immune cells to induce effective immune responses against 
pathogens. Immunohistochemical analysis indicated splenic 
macro phages have reductions in expression of MHC Class II 
suggesting impairments in antigen presentation (Figure  6A). 
This is comparable to data from monocytes isolated from 
stroke patients which showed reduced HLA-DR expression 
in comparison to those isolated from healthy controls (69). 
Furthermore splenic gene expression analysis showed reduced 
expression of genes associated with co-stimulation of adaptive 
immune responses (Figure 7C) and pro-inflammatory cytokine 
production (Figure  7E) suggesting macrophage ability to 
directly present antigen to cells of the adaptive immune system 
is likely to be impaired. We additionally showed that reduced 
expression of MHC class II occurred in a subset specific manner 
and that splenic macrophage subsets associated with increased 
phagocytosis after experimental stroke were also associated 
with reduced capacity to present antigen on MHC Class II. 
This may indicate activation of mechanisms designed to reduce 
autoreactive responses to self-antigen from phagocytosis of 
apoptotic cells. Gene expression data indicated that deficits in 
antigen presentation were unlikely to be associated with deficits 
in phagocytosis or the ability to generate peptide antigen via 
processing by cathepsins as genes associated with these pro-
cesses (Lamp2, Ctsl) were upregulated after experimental stroke 
(Figure 4). Instead this was more likely to be due to reduced 
expression of genes involved in expression of MHC class II in 
addition to those involved in stabilizing the MHC Class II invari-
ant chain (Cd74) and loading complete MHC Class II molecules 
with peptide (HLA-DM; Figure  6). However, cells with more 
potent antigen presenting and adaptive immune cell activation 
abilities, such as CD11c+ DC, showed no reduction in MHC 
Class II immunolabelling suggesting some capacity for antigen 
presentation and activation of adaptive immune responses 
within the spleen still remains (Figures  6B,D). Macrophages 
additionally contribute to adaptive immune responses via the 
capture of circulating antigen in the MZ and subsequent trans-
port of intact antigen to FDC in the B cell follicle; an essential 
mechanism for the selection of high affinity B cells in the GC 
reaction (33, 55). Despite increased phagocytic activity of MZM 
(Figure 4), antigen capture by MZM and transport to the follicle 
was unaffected by experimental stroke (Figure 5) suggesting that 
macrophage provision of intact antigen to the FDC network to 
facilitate B cell affinity maturation is unaffected. Infections fre-
quently occur within the first week after stroke onset; therefore, 
reported deficits in macrophage activation of adaptive immune 
responses, which are slowly activated, are unlikely to account 
for early susceptibility to infection but instead may contribute to 
an inability to clear infection at later stages (13, 70, 71).
Previous reports have shown peripheral monocytes from 
stroke patients are less able to produce the inflammatory cytokine 
TNFα upon in  vitro stimulation (12). In agreement with this, 
concentrations of TNFα were reduced in spleens after experi-
mental stroke (Figures 7E–G). In combination with deficits in 
co-stimulatory molecule and class II MHC gene expression, this 
suggests macrophage ability to communicate with and activate 
other immune cells, by both direct contact and soluble mediators 
such as cytokines, was compromised. Macrophage recruitment 
and activation of innate immune cells may contribute to patient 
susceptibility to infection early after stroke in addition to deficits 
in inducing later adaptive immune responses.
In conclusion, our study reveals that subpopulations of splenic 
macrophages are differentially affected by experimental stroke 
reflecting the heterogeneity of macrophages within the spleen. 
Furthermore, although some evidence of functional deactivation 
was observed, this did not affect all macrophage subsets and other 
effector functions remained intact, or even augmented, after 
experimental stroke. Further functional studies to definitively 
assess the capabilities of individual splenic macrophage subpopu-
lations after stroke are warranted to fully understand the implica-
tions of these changes to infection susceptibility after stroke. The 
heterogeneity in response will be important to consider when 
investigating therapeutic approaches to combat SAI. For example, 
deficits in MHC class II expression on monocytes/macrophages 
has been widely reported; however, non-specific augmentation 
of MHC Class II expression on all macrophage subsets could 
increase expression on subsets that do not show any deficit after 
experimental stroke and push responses toward an autoimmune 
phenotype with detrimental results long term. In conclusion, 
selected systemic macrophage functions may provide potential 
therapeutic targets to reduce SAI and improve clinical outcome; 
however, it is likely that a subset-targeted approach will be optimal.
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